These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1573657)

  • 1. A swift response to a "modest" proposal.
    Cova JL
    J Natl Cancer Inst; 1992 May; 84(10):744-5. PubMed ID: 1573657
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal for assuring technology competency and leadership in medicine.
    McGivney WT
    J Natl Cancer Inst; 1992 May; 84(10):742-4. PubMed ID: 1573656
    [No Abstract]   [Full Text] [Related]  

  • 3. Assigning care costs associated with therapeutic oncology research: a modest proposal.
    Friedman MA; McCabe MS
    J Natl Cancer Inst; 1992 May; 84(10):760-3. PubMed ID: 1573661
    [No Abstract]   [Full Text] [Related]  

  • 4. Who should be responsible?
    Brown E
    Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532
    [No Abstract]   [Full Text] [Related]  

  • 5. Will insurers pay for high-tech care?
    Crane M
    Med Econ; 1991 Apr; 68(8):82-6. PubMed ID: 10110091
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental therapy--who shall pay?
    N Engl J Med; 1991 May; 324(18):1291-2. PubMed ID: 2014045
    [No Abstract]   [Full Text] [Related]  

  • 7. How can Medicare keep pace with cutting-edge technology?
    Buto KA
    Health Aff (Millwood); 1994; 13(3):137-40. PubMed ID: 7927144
    [No Abstract]   [Full Text] [Related]  

  • 8. Popping the cost balloon. Angioplasty study should be a harbinger, but budgets, entropy stall reform.
    Sloane T
    Mod Healthc; 2007 Apr; 37(15):21. PubMed ID: 17494354
    [No Abstract]   [Full Text] [Related]  

  • 9. HCFA sets new tech coverage criteria.
    Becker C
    Mod Healthc; 2000 Jul; 30(28):32. PubMed ID: 11184157
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining experimental therapy--a third-party payer's dilemma.
    Newcomer LN
    N Engl J Med; 1990 Dec; 323(24):1702-4. PubMed ID: 2233969
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of medical technology policies shows need, opportunities for changes.
    Banta D
    Hospitals; 1982 Apr; 56(7):87-90. PubMed ID: 6800914
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of medical-technology strategies: effects of coverage and reimbursement (first of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(10):620-4. PubMed ID: 7035944
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomedical research and technology development.
    Anderson GF; Russe GM
    Health Aff (Millwood); 1987; 6(2):85-92. PubMed ID: 3623411
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of medical-technology strategies: proposal for an institute for health-care evaluation (second of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(11):687-92. PubMed ID: 7035949
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of American Physicians. Presidential address.
    Relman AS
    Trans Assoc Am Physicians; 1984; 97():lxxxiv-xci. PubMed ID: 6535332
    [No Abstract]   [Full Text] [Related]  

  • 16. Summary of a workshop on the role of third-party payers in clinical trials of new agents.
    Chalmers TC; van den Noort S; Lockshin MD; Waksman BH
    N Engl J Med; 1983 Nov; 309(21):1334-6. PubMed ID: 6633594
    [No Abstract]   [Full Text] [Related]  

  • 17. Investment in health care innovation.
    Pollard MR; Persinger GS
    Health Aff (Millwood); 1987; 6(2):93-106. PubMed ID: 3114113
    [No Abstract]   [Full Text] [Related]  

  • 18. Access to investigational treatments.
    Ader M
    Health Matrix Clevel; 1996; 6(1):187-99. PubMed ID: 10167167
    [No Abstract]   [Full Text] [Related]  

  • 19. Technology development from the perspective of industry.
    Abele JE
    J Invasive Cardiol; 1993 Mar; 5(2):65-8. PubMed ID: 10171667
    [No Abstract]   [Full Text] [Related]  

  • 20. The National Institutes of Health and their sponsorship of clinical trials.
    Hawkins BS
    Control Clin Trials; 1988 Jun; 9(2):103-6. PubMed ID: 3396361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.